BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31642546)

  • 1. CD4
    Makiyama J; Kobayashi S; Watanabe E; Ishigaki T; Kawamata T; Nakashima M; Yamagishi M; Nakano K; Tojo A; Watanabe T; Uchimaru K
    Cancer Sci; 2019 Dec; 110(12):3746-3753. PubMed ID: 31642546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
    Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
    Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma.
    Kobayashi S; Nakano K; Watanabe E; Ishigaki T; Ohno N; Yuji K; Oyaizu N; Asanuma S; Yamagishi M; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
    Clin Cancer Res; 2014 Jun; 20(11):2851-61. PubMed ID: 24727323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.
    Kagdi HH; Demontis MA; Fields PA; Ramos JC; Bangham CR; Taylor GP
    Cancer Med; 2017 Jan; 6(1):298-309. PubMed ID: 28035765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
    Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
    Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I.
    Kobayashi S; Tian Y; Ohno N; Yuji K; Ishigaki T; Isobe M; Tsuda M; Oyaizu N; Watanabe E; Watanabe N; Tani K; Tojo A; Uchimaru K
    PLoS One; 2013; 8(1):e53728. PubMed ID: 23349737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
    Cook LB; Taylor GP
    Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
    Nakahata S; Morishita K
    J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study.
    Umekita K; Hashikura Y; Takaki A; Kimura M; Kawano K; Iwao C; Miyauchi S; Kawaguchi T; Matsuda M; Hashiba Y; Hidaka T
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-clonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia.
    Hata T; Fujimoto T; Tsushima H; Murata K; Tsukasaki K; Atogami S; Sohda H; Honda S; Mine M; Yamada Y; Ikeda S; Kamihira S; Tomonaga M
    Leukemia; 1999 Feb; 13(2):215-21. PubMed ID: 10025895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
    Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
    Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
    Nakahata S; Saito Y; Marutsuka K; Hidaka T; Maeda K; Hatakeyama K; Shiraga T; Goto A; Takamatsu N; Asada Y; Utsunomiya A; Okayama A; Kubuki Y; Shimoda K; Ukai Y; Kurosawa G; Morishita K
    Leukemia; 2012 Jun; 26(6):1238-46. PubMed ID: 22289924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 bZIP f